Treatment of low-risk myelodysplastic syndromes by erythroprotein and its derivatives

被引：0
作者：
Villeval, Jean-Luc [1 ]
Sainty, Danielle [2 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Paoli Calmettes, Marseille, France
来源：
HEMATOLOGIE | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
[21]   Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes [J].
Tamburini, J. ;
Elie, C. ;
Park, S. ;
Beyne-Rauzy, O. ;
Gardembas, M. ;
Berthou, C. ;
Mahe, B. ;
Sanhes, L. ;
Stamatoullas, A. ;
Vey, N. ;
Aouba, A. ;
Slama, B. ;
Quesnel, B. ;
Vekhoff, A. ;
Sotto, J. J. ;
Vassilief, D. ;
Al-Nawakil, C. ;
Fenaux, P. ;
Dreyfus, F. ;
Bouscary, D. .
LEUKEMIA RESEARCH, 2009, 33 (04) :547-550
[22]   Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes [J].
Ma, Xiaomei ;
Wang, Rong ;
Galili, Naomi ;
Mayne, Susan T. ;
Wang, Sa A. ;
Yu, Herbert ;
Raza, Azra .
CANCER CAUSES & CONTROL, 2011, 22 (04) :623-629
[23]   Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes [J].
Tehranchi, R .
MEDICAL ONCOLOGY, 2006, 23 (01) :37-49
[24]   Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes [J].
R. Tehranchi .
Medical Oncology, 2006, 23 (1) :37-49
[25]   Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features [J].
Fattizzo, Bruno ;
Serpenti, Fabio ;
Versino, Francesco ;
Cassanello, Giulio ;
Cro, Lilla M. ;
Barbieri, Marzia ;
Croci, Giorgio A. ;
Revelli, Nicoletta ;
Porta, Matteo G. Della ;
Barcellini, Wilma .
BLOOD TRANSFUSION, 2023, 21 (05) :452-460
[26]   Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes [J].
Xiaomei Ma ;
Rong Wang ;
Naomi Galili ;
Susan T. Mayne ;
Sa A. Wang ;
Herbert Yu ;
Azra Raza .
Cancer Causes & Control, 2011, 22 :623-629
[27]   Part 4: Myelodysplastic syndromes-Treatment of low-risk patients with the 5q deletion [J].
Meira Magalhaes, Silvia Maria ;
Pereira Velloso, Elvira Deolinda Rodrigues ;
Buzzini, Renata ;
Bernardo, Wanderley Marques .
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (03) :274-277
[28]   Hypochromic red blood cells in low-risk myelodysplastic syndromes:: effects of treatment with hemopoietic growth factors [J].
Ljung, T ;
Bäck, R ;
Hellström-Lindberg, E .
HAEMATOLOGICA, 2004, 89 (12) :1446-1453
[29]   An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes [J].
Teodorescu, Patric ;
Pasca, Sergiu ;
Choi, Inyoung ;
Shams, Cynthia ;
Dalton, W. Brian ;
Gondek, Lukasz P. ;
DeZern, Amy E. ;
Ghiaur, Gabriel .
HAEMATOLOGICA, 2024, 109 (01) :337-342
[30]   Luspatercept: a candidate to dethrone erythropoietin in first line in low-risk myelodysplastic syndromes? [J].
Robert-Van Houtteghem, Tristan .
HEMATOLOGIE, 2023, 29 (05) :269-271
12345